Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study …
V Solitano, H Prins, M Archer, L Guizzetti… - Crohn's & Colitis …, 2024 - academic.oup.com
Background A better understanding of motivations to participate as well as
recommendations to reduce barriers to enrollment may assist in design of future clinical …
recommendations to reduce barriers to enrollment may assist in design of future clinical …
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study …
V Solitano, H Prins, M Archer, L Guizzetti… - Crohn's & Colitis …, 2024 - europepmc.org
Background A better understanding of motivations to participate as well as
recommendations to reduce barriers to enrollment may assist in design of future clinical …
recommendations to reduce barriers to enrollment may assist in design of future clinical …
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study …
V Solitano, H Prins, M Archer… - Crohn's & colitis …, 2024 - pubmed.ncbi.nlm.nih.gov
Background A better understanding of motivations to participate as well as
recommendations to reduce barriers to enrollment may assist in design of future clinical …
recommendations to reduce barriers to enrollment may assist in design of future clinical …
[HTML][HTML] Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of …
V Solitano, H Prins, M Archer, L Guizzetti… - Crohn's & Colitis …, 2024 - ncbi.nlm.nih.gov
Background A better understanding of motivations to participate as well as
recommendations to reduce barriers to enrollment may assist in design of future clinical …
recommendations to reduce barriers to enrollment may assist in design of future clinical …
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study …
V Solitano, H Prins, M Archer, L Guizzetti… - Crohn's & Colitis …, 2024 - academic.oup.com
Background A better understanding of motivations to participate as well as
recommendations to reduce barriers to enrollment may assist in design of future clinical …
recommendations to reduce barriers to enrollment may assist in design of future clinical …
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study …
L Guizzetti, V Jairath - 2024 - europepmc.org
Background A better understanding of motivations to participate as well as
recommendations to reduce barriers to enrollment may assist in design of future clinical …
recommendations to reduce barriers to enrollment may assist in design of future clinical …